ALBANY, New York, January 24, 2018 /PRNewswire/ --
Global Point-of-care Diagnostics Market: Design of Advanced Devices for Non-invasive Detection to Bolster Demand
According to the report, the point-of-care diagnostics market is projected to expand at a CAGR of 6.9% from 2016 to 2024 to reach US$ 11.7 Bn by 2024.
Point-of-care (PoC) Diagnostics is carried out
View Report Preview at https://www.transparencymarketresearch.com/care-diagnostics-market.html
Increasing number of chronic diseases such as cancer, diabetes, cardiovascular diseases, etc., growing geriatric population, technological innovations, favorable insurance and reimbursement policies, and rising per capita health care expenditure would drive the growth of point-of-care diagnostics market. Cancer is the leading cause of death across the world. According to the WHO, The growing prevalence of cancer was 32.6 million globally in 2012, and 14 million new cases of cancer were diagnosed worldwide. Technological advancements are the another factor fuel the point-of-care market in developing as well as developed contries.Sensor technologies, which is used for rapid analysis of blood samples for several healthcare conditions, including blood chemistry, electrolytes, blood gases, and hematology. Point-of-care test can be an effective way to improve patients healthcare outcomes and is essential for large populations in rural areas where healthcare facilities are underdeveloped. Solid phase assay test is expected to grow at a higher rate owing to several advantages such as, multiple parameters can be tested in a single strip, and small amount of sample is required for test and easy diagnostic procedure.
Request to View Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1128
The lateral flow assay test segment accounted for a largest share of the global point-of-care diagnostics market. Lateral flow assay test is mostly preferred because of affordability, stability of product and easy diagnostic procedure. Lateral flow tests are the simplest type of rapid diagnostic test with no equipment to perform. In addition, factors such as growing population, rising health care expenditure, and favorable reimbursement policies support the growth of the segment in developing countries such as Brazil, China, and India.
In developing countries lateral flow assay tests are mainly utilized for infectious disease testing such as HIV, malaria, tuberculosis, influenza testing, etc. According to the World Health Organization (WHO), in developing countries more than 29 million people were tested with HIV infection. Technological advancements such as array and sensor based technologies as well as microfluidic technology will increase the demand for lateral flow assay test segment. The other advantages of lateral flow assay tests are easy availability of manufacturing material, easy manufacturing of product, easy to produce high volume of product, relatively low cost than other point-of-care test and takes short time period for development and approval as well as high market presence and acceptance among people.
Download PDF Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1128
The lateral flow assay test segment was closely followed by other PoC tests such as flow through test, solid phase assay test and agglutination assay test. Flow through tests are stable at room temperature and does not require any cold chain transport system, and produces instant results, hence, will experience growth during the forecast period. Solid phase assay tests are also expected to witness high growth during the forecast period due to the associated benefits of these tests over other tests.
Major players in the global point-of-care diagnostics market are Alere, Inc., Abbott Laboratories, Becton Dickinson & Co., F. Hoffman La Roche Ltd., Bio-Rad Laboratories, Inc. Abaxis, and Trinity Biotech, Inc. among others.
Buy Point-of-care Diagnostics Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=1128<ype=S
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact Transparency Market Research State Tower 90 State Street, Suite 700, Albany, NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: firstname.lastname@example.org
Research Blog: http://theglobalhealthnews.com/
SOURCE Transparency Market Research
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All